Ahmad Alyamani

The Royal Wolverhampton NHS Trust

Papers

1

Total Citations

4

H-Index

1

About

Ahmad Alyamani is a rising surgical researcher whose work focuses on advancing minimally invasive techniques in colorectal cancer treatment, particularly through robotic and transanal total mesorectal excision (TME). His major contribution is a comprehensive systematic review and meta-analysis comparing robotic versus transanal TME for rectal cancer, evaluating peri-operative, oncological, and functional outcomes. This 2024 study, already garnering 4 citations, synthesizes critical evidence to guide surgeons in selecting optimal approaches for patients, highlighting his ability to distill complex clinical data into actionable insights. Alyamani’s work addresses a pressing need in colorectal surgery—balancing cancer clearance with quality of life—and his meta-analysis serves as a key reference for ongoing debates in the field. While early in his career, his focus on high-impact, evidence-based synthesis positions him as a promising contributor to surgical oncology. His research not only informs current practice but also sets the stage for future trials, making him a researcher to watch for students and clinicians interested in the evolution of rectal cancer surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Peri-operative, oncological and functional outcomes of robotic versus transanal total mesorectal excision in patients with rectal cancer: A systematic review and meta-analysis
4 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: The Royal Wolverhampton NHS Trust

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago